リコンビナント
RabMAb

Anti-ELK1 抗体 [E277] - ChIP Grade (ab32106)

ab32106 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab32106 は 19 報の論文で使用されています。

  • Shuang T  et al. NF-?B1, c-Rel, and ELK1 inhibit miR-134 expression leading to TAB1 upregulation in paclitaxel-resistant human ovarian cancer. Oncotarget 8:24853-24868 (2017). ChIP . PubMed: 28206956
  • Osmanbeyoglu HU  et al. Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs. Nat Commun 8:14249 (2017). PubMed: 28139702
  • Yan Q  et al. SPAG9 is involved in hepatocarcinoma cell migration and invasion via modulation of ELK1 expression. Onco Targets Ther 9:1067-75 (2016). WB, IHC . PubMed: 27042099
  • Chen X  et al. Genome-wide binding studies reveal DNA binding specificity mechanisms and functional interplay amongst Forkhead transcription factors. Nucleic Acids Res 44:1566-78 (2016). PubMed: 26578569
  • Rosati R  et al. The Amino-terminal Domain of the Androgen Receptor Co-opts Extracellular Signal-regulated Kinase (ERK) Docking Sites in ELK1 Protein to Induce Sustained Gene Activation That Supports Prostate Cancer Cell Growth. J Biol Chem 291:25983-25998 (2016). PubMed: 27793987
  • Bullock M  et al. Thyroid transcription factor FOXE1 interacts with ETS factor ELK1 to co-regulate TERT. Oncotarget 7:85948-85962 (2016). IP, ChIP ; Human . PubMed: 27852061
  • Aguilar-Martinez E  et al. The ubiquitin ligase UBE3A dampens ERK pathway signalling in HPV E6 transformed HeLa cells. PLoS One 10:e0119366 (2015). PubMed: 25815718
  • Jilg CA  et al. PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells. Oncotarget 5:12646-64 (2014). PubMed: 25504435
  • Sillivan SE  et al. ELK1 transcription factor linked to dysregulated striatal mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers. Biol Psychiatry 74:511-9 (2013). IP ; Human . PubMed: 23702428
  • Odrowaz Z & Sharrocks AD The ETS transcription factors ELK1 and GABPA regulate different gene networks to control MCF10A breast epithelial cell migration. PLoS One 7:e49892 (2012). ChIP ; Human . PubMed: 23284628
  • Odrowaz Z & Sharrocks AD ELK1 uses different DNA binding modes to regulate functionally distinct classes of target genes. PLoS Genet 8:e1002694 (2012). WB, ChIP ; Human . PubMed: 22589737
  • Lee K  et al. S100A2 promoter-driven conditionally replicative adenovirus targets non-small-cell lung carcinoma. Gene Ther 19:967-77 (2012). PubMed: 22033466
  • Gregg J & Fraizer G Transcriptional Regulation of EGR1 by EGF and the ERK Signaling Pathway in Prostate Cancer Cells. Genes Cancer 2:900-9 (2011). ChIP . PubMed: 22593802
  • Booy EP  et al. Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer. Oncogene 30:2367-78 (2011). ICC/IF ; Human . PubMed: 21258408
  • Lee SM  et al. Activation and repression of cellular immediate early genes by serum response factor cofactors. J Biol Chem 285:22036-49 (2010). PubMed: 20466732
  • O'Geen H  et al. Genome-wide binding of the orphan nuclear receptor TR4 suggests its general role in fundamental biological processes. BMC Genomics 11:689 (2010). ChIP . PubMed: 21126370
  • Boros J  et al. Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery. Genome Res 19:1963-73 (2009). PubMed: 19687146
  • Boros J  et al. Overlapping promoter targeting by Elk-1 and other divergent ETS-domain transcription factor family members. Nucleic Acids Res 37:7368-80 (2009). PubMed: 19789270
  • Zhang L  et al. Rev7/MAD2B links c-Jun N-terminal protein kinase pathway signaling to activation of the transcription factor Elk-1. Mol Cell Biol 27:2861-9 (2007). PubMed: 17296730

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録